Ann: Successful ELi Purification Pilot Trial, page-25

It halved in 3 months, after already dropping 70% in the proceeding 9 months.

I guess a doubling in price after (my speculation) a dilutive raise for $25m at around $0.18c for almost 140m shares on the 550m existing shares for a total of 690m shares - or an extra 25% more shares could be considered a win...

But I think this would only be a win if you were only to consider shares purchased at lows, but heaven forbid if your initial purchase was anything above $0.50c, it'll potentially be a long time before the share price revisits those highs.

The share price would need to go back to about $0.40c to have a $275m market cap, which is the equivalent of a $0.50c share price pre raise at the figures I suggest.

Who knows, there may be an asset sale for a "sugar rush" (short lived) cash injection, but I would consider that a failure in terms of value realisation in a strategic sense.

Don't get me wrong, I'm watching from the sidelines, but I think there is more pain than pleasure in the near term.

The AGM should be interesting - "if technical difficulties don't prevent us from watching it".